Title:
ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES
Document Type and Number:
WIPO Patent Application WO2006133144
Kind Code:
A8
Abstract:
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production, including pure red cell aplasia (PRCA). Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
More Like This:
| JP4624801 | Herbicidal composition |
| JP3053480 | COATING COMPOSITION FOR PREVENTING ANIMAL BITING DAMAGE |
| JP4015788 | Pest control agent |
Inventors:
DULIEGE ANNE-MARIE (US)
STEAD RICHARD (US)
LEUTHER KERSTIN (US)
WOODBURN KATHRYN (US)
NASO ROBERT BARNETT (US)
STEAD RICHARD (US)
LEUTHER KERSTIN (US)
WOODBURN KATHRYN (US)
NASO ROBERT BARNETT (US)
Application Number:
PCT/US2006/021845
Publication Date:
April 17, 2008
Filing Date:
June 05, 2006
Export Citation:
Assignee:
AFFYMAX INC (US)
DULIEGE ANNE-MARIE (US)
STEAD RICHARD (US)
LEUTHER KERSTIN (US)
WOODBURN KATHRYN (US)
NASO ROBERT BARNETT (US)
DULIEGE ANNE-MARIE (US)
STEAD RICHARD (US)
LEUTHER KERSTIN (US)
WOODBURN KATHRYN (US)
NASO ROBERT BARNETT (US)
International Classes:
A01N37/18; A61K38/00; C07K16/00
Download PDF:
Previous Patent: SURGICAL MICROSCOPE DRAPE WITH REMOVABLE LENS ASSEMBLY
Next Patent: TAT-007 AND METHODS OF ASSESSING AND TREATING CANCER
Next Patent: TAT-007 AND METHODS OF ASSESSING AND TREATING CANCER